Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its indirect subsidiary, ACEA Therapeutics, Inc, ACEA Pharma, Inc., and Phoenix Asia Holdings Limited, a company organized under the laws of the Cayman Islands (“Phoenix”) (Nasdaq: PHOE), entered into a stock acquisition agreement pursuant to which ACEA Thera agreed to transfer and sell, and Phoenix agreed to purchase, 100% of the issued and outstanding equity interests of ACEA Pharma.
Read the full article: Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited //
Source: https://www.globenewswire.com/news-release/2026/05/05/3288095/0/en/scilex-holding-company-announces-its-subsidiaries-acea-therapeutics-inc-and-acea-pharma-inc-entered-into-a-definitive-agreement-with-phoenix-asia-holdings-limited.html?_gl=1*q3538f*_up*MQ..*_ga*OTY5NzY4NjkwLjE3NzgwMDg3MTM.*_ga_B6167QB2TF*czE3NzgwMDg3MTIkbzEkZzAkdDE3NzgwMDg3MTIkajYwJGwwJGg5MzQ2NTg4NzM.*_ga_ERWPGTJ5X8*czE3NzgwMDg3MTIkbzEkZzAkdDE3NzgwMDg3MTIkajYwJGwwJGgw